Kelley Hargett
About Kelley Hargett
Kelley Hargett is an Oncology Account Manager currently employed at Mirati Therapeutics in Fort Worth, Texas. With extensive experience in oncology sales and management, Hargett has held various roles at notable companies including AstraZeneca, Amgen, and Natera.
Work at Mirati Therapeutics
Kelley Hargett currently serves as an Oncology Account Manager at Mirati Therapeutics, a role she has held since 2022. Based in Fort Worth, Texas, she focuses on oncology-related accounts, leveraging her extensive experience in the pharmaceutical industry to drive business growth and enhance patient access to innovative therapies.
Previous Experience at AstraZeneca
Kelley Hargett has held multiple positions at AstraZeneca, contributing to her expertise in oncology. She worked as an Executive Pharmaceutical Sales Specialist in Oncology from 2018 to 2020 in the Dallas/Fort Worth Area. After a brief tenure at Natera, she returned to AstraZeneca, where she served as Executive Pharmaceutical Sales Specialist Oncology from 2020 to 2021, and later as Precision Medicine Manager-Pan Tumor for four months in 2022.
Clinical Oncology Specialist Role
In 2020, Kelley Hargett worked as a Clinical Oncology Specialist at Natera for four months in the Dallas-Fort Worth Metroplex. This position allowed her to deepen her understanding of clinical oncology and enhance her skills in managing oncology-related accounts.
Experience at Amgen and Akcea Therapeutics
Before her time at AstraZeneca, Kelley Hargett worked at Amgen as a Senior Biopharmaceutical Representative in Oncology from 2017 to 2018 in Santa Monica, California. Additionally, she was a Rare Disease Specialist at Akcea Therapeutics for seven months in 2018 in the Greater Los Angeles Area, further broadening her expertise in the biopharmaceutical sector.